missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Lysates
  5. Overexpression Lysates
  6. 18256013

Novus Biologicals™ BID Overexpression Lysate

Product Code. 18256013 Shop All Bio Techne Products
Click to view available options
:
0.1 mg
This item is not returnable. View return policy

Product Code. 18256013

Brand: Novus Biologicals™ NBL107979

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

The BID Overexpression Lysate is derived from human. It has been validated for the following applications: Western Blot.
TRUSTED_SUSTAINABILITY

Specifications

Cell Line The lysate was created in HEK293T cells, using plasmid ID RC27261 and based on accession number NM_1196. The protein contains a C-terminal DDK tag.
For Use With (Application) Western Blot
Quantity 0.1 mg
Storage Buffer RIPA buffer
Purity Protein
Test Specificity Homo sapiens BH3 interacting domain death agonist (BID), transcript variant 2, mRNA.
Content And Storage Store at -80 C. Avoid freeze-thaw cycles.
Research Category Apoptosis, Cancer, Tumor Suppressors
Target BID
Synonym apoptic death agonist, BH3 interacting domain death agonist, BH3-interacting domain death agonist, BID isoform ES(1 b), BID isoform L(2), BID isoform Si6, desmocollin type 4, FP497, Human BID coding sequence, MGC15319, MGC42355, p22 BID, tbid
Gene Symbol BID
Protein State Native
Show More Show Less

For Research Use Only

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.